Trump Seizes the Momentum Back

Donald Trump’s announcement of a major drug pricing executive order, an apparent breakthrough in trade talks with China, and a slew of other smaller victories indicate that the president isn’t slowing down in delivering on his ambitious second-term agenda.

In every presidency, there are inflection points that determine how successful a president will be, and which ultimately define his legacy. Trump appears to be emerging on the other side of the first such moment of his second term and may be seizing back political momentum following a temporary lull.

When Trump stormed back to office last November, his decisive victory left Democrats in shambles. The liberal party lost the White House, House, and Senate and was mired in an internal ideological civil war. Moderates cried that Joe Biden and Kamala Harris had taken the party too far left. The emergent progressive wing, meanwhile, insisted that the problem was really that Democrats weren’t liberal enough.

While Democrats were busy fighting amongst themselves, Trump took the oath of office for the second time and unleashed one of the most historic first 100 days of any president in history. His “shock and awe” strategy on everything from shutting down the border to renaming the Gulf of Mexico to the Gulf of America kept Democrats on their heels and cemented Republicans in the driver’s seat.

But as is always the case in American politics, the opposition party slowly began to regroup. Democrats (and their erstwhile corporate media allies) saw an opening in the market turbulence brought on by Trump’s tariffs, seizing on the opportunity to claim that Trump was not delivering on his promise of economic resurgence.

Of course, that line of attack was always undercut by the fact that Trump successfully brought inflation down to under 2.5 percent and the trillions of dollars of investment pouring into the country. Nonetheless, liberals had a talking point to rally around, no matter how flimsy it was.

Democrats also found common cause in opposing the Trump administration’s deportation efforts and government efficiency push. While defending criminal illegal aliens and career bureaucrats isn’t likely to be a long-term winning play, the party was finally able to drive its own narrative by relying on emotional appeals.

Congressional Republicans haven’t helped Trump out, either. The fate of the president’s domestic agenda hangs in the balance of negotiations over a budget reconciliation package that has already been delayed twice. House Speaker Mike Johnson is now hopeful it will pass the House before the Memorial Day recess at the end of this month.

All of these factors combined to create the sense that Trump may be losing the runaway momentum that characterized the early weeks of his second term. But now the president may be re-seizing the initiative.

Reports that the United States and China had reached an agreement to dramatically slash tariffs for 90 days amid ongoing talks represented the first major breakthrough for the administration.

From the moment Trump launched his tariff campaign, he made clear that they were an economic tool to reduce America’s trade deficit with foreign nations and restore the American manufacturing sector. While elected Democrats and the media obsessed over the falling stock market, dozens of countries quickly lined up to renegotiate their trade arrangements with the United States.

Following new deals with Canada and the United Kingdom, forcing China to the negotiating table is by far Trump’s most significant trade victory to date. It vindicates his belief that a trade war between China and the U.S. hurts China more and confirms that Trump’s team holds the leverage in trade talks.

At the same time, Trump’s long-term trade strategy coming to fruition is quietly erasing the market’s temporary downturn – erasing Democrats’ primary economic talking point along with it.

At the same time as news of the U.S.-China trade truce broke, Trump also announced a new executive order that he says will reduce the cost of prescription drugs and pharmaceuticals “almost immediately by 30% to 80%.”

Bringing down prescription drug prices was one of Trump’s signature healthcare goals during his first administration – a policy so successful that Biden attempted to claim credit for it as well. Trump’s new order will specifically institute “a most favored nations policy whereby the United States will pay the same price as the nation that pays the lowest price anywhere in the world.”

Just as was the case in the early days of his term, Trump’s bold actions are once again driving the news. Like a boxer in the ring, Trump has fended off his opponent’s counterattack and now appears to be back on the offensive. Democrats will be hard-pressed to find anything to criticize in these recent moves.

There will certainly be more challenges to come for the 47th president over the next three and a half years. But once again, Trump has proven himself a master strategist and deft political operator.

Shane Harris is the Editor-in-Chief of AMAC Newsline. You can follow him on X @shaneharris513.